Differential (Click to cross reference) acetylcholine receptor acetylcholine receptor antibody adverse drug reaction algorithm aminoacidopathies atypical autoantibodies autoimmune disease azathioprine brain atrophy carcinoma carcinoma of thyroid chemotherapy, CNS treatment and complications with cirrhosis cirrhosis, infancy comorbidities contractures, joint critical care unit developmental milestones, loss of diplopia dopa responsive dystonia dysarthria dystonia dystonia, children efficacy emergencies, neurologic encephalopathy encephalopathy, progressive enzyme, defect epidemiology of neurology familial fatigue galactorrhea gammaglobulin therapy, intravenous gene mutation genetic neurologic disorders genetic screening genetic testing headache headache, severe hepatic failure HLA hypertension hypertonia hyponatremia hyporeflexia iatrogenic neurologic disorders ileus, paralytic immunosuppressive agents inborn errors of metabolism L-dopa lenvatinib level of consciousness, decreased lipoprotein receptor-related protein 4 liver disease monoclonal antibodies mortality movement disorder MRI, abnormal muscle weakness MuSK antibodies myasthenia gravis myasthenia gravis, classification myasthenia gravis, diagnosis myasthenia gravis, drug resistant myasthenia gravis, ocular myasthenia gravis, receptor site in myasthenia gravis, seronegative myasthenia gravis, thymectomy in myasthenia gravis, treatment of myasthenia gravis, variants myasthenic crisis myocarditis narcolepsy neoplasm, metastatic nerve biopsy neurologic disease, diagnoses of neuromuscular junction neuromuscular junction, abnormality of neuromyelitis optica (Devic's disease) neuropathy neuropathy, painful neuropathy, peripheral ophthalmoplegia pain plasmapheresis posterior leukoencephalopathy syndrome practice guidelines pregnancy, neurologic complications in prognosis progressive neurologic disorder prolactin, elevated ptosis ptosis, bilateral quality of life receptor tyrosine kinase inhibitor respiratory failure reversible cerebral vasoconstrictive syndromes review article rituximab safety scoliosis seizure self-mutilation seronegative speech disorder speech disorder, childhood steroid steroid therapy, CNS treatment and complications with thymectomy thymic hyperplasia thymoma thyroiditis treatment of neurologic disorder tyrosine tyrosine hydroxylase deficiency tyrosinemia weakness weakness, fatiguable weakness, generalized wheelchair white matter disease

Showing articles 0 to 10 of 10 A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy JAMA Neurol 81:83-84, Hua,L.,et al, 2024 Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects JENDSO 6:1-7, Hamidi, S.,et al, 2022 Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022 Rituximab as Treatment for anti-MuSK myasthenia gravis Neurol 89:1069-1077, Hehir, M.K.,et al, 2017 Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia Neurol 78:189-193, Diaz-Manera,J.,et al, 2012 Are MuSK Antibodies the Primary Cause of Myasthenic Symptoms? Neurol 62:1945-1950,1920, Selcen,D.,et al, 2004 Neurologic Crises in Hereditary Tyrosinemia NEJM 322:432-437, Mitchell,G.,et al, 1990 Treatment of Narcolepsy with L-Tyrosine:Double-Blind Placebo-Controlled Trial Lancet 2:1067-1069, Elwes,R.D.,et al, 1989 Treatment of Narcolepsy with L-Tyrosine Lancet 2:1458-1459, Mouret,J.,et al, 1988 Showing articles 0 to 10 of 10